A Multicenter Prospective Study for Patient Perception of Treatment Satisfaction After Switching to Mirabegron in Patients With Overactive Bladder Who Were Unsatisfied With Efficacy of Antimuscarinic Therapy or Adverse Event.
Phase of Trial: Phase IV
Latest Information Update: 05 Mar 2018
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 26 Feb 2018 Status changed from not yet recruiting to completed.
- 17 Jun 2015 New trial record